Wilmer Cutler Pickering Hale and Dorr represented Choice Hotels International, Inc. in the offering, and Cahill Gordon & Reindel represented the underwriters. Choice Hotels International, Inc....
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented MicroStrategy Incorporated in the offering. MicroStrategy® Incorporated (Nasdaq: MSTR) (“MicroStrategy”) announced that it has completed its offering of 2.25%...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Disc Medicine, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriter. Disc Medicine, Inc. (Nasdaq: IRON) (“Disc”) announced...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Medtronic, Inc. in the offering. Medtronic plc (NYSE: MDT) announced it closed its €3 billion public offering, consisting of...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Eko Health in the transaction. Eko Health, a pioneer in applying artificial intelligence for early detection of heart and...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Gameto on the deal, and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Two Sigma Ventures. Gameto, a biotechnology...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Agios Pharmaceuticals, Inc. in the deal. Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Dyne Therapeutics, Inc. on the offering, and Cooley advised the underwriters. Dyne Therapeutics, Inc. (Nasdaq:DYN) announced the closing of...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Orna Therapeutics on the transaction. Orna Therapeutics, a biotechnology company, announced its acquisition of ReNAgade Therapeutics, a pioneer in...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised MKS Instruments, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers. MKS...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Monitaur on the transaction. Monitaur, the premier model governance software company for highly regulated companies and their partners, announced...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Apellis Pharmaceuticals, Inc. on the deal, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo and Proskauer Eose advised Sixth...
You must be a Standard 1 Year member to access this content.
